Quick Answer
International Stem Cell CORP reported Total Assets of $4.82 million for the year ending 2025.
- International Stem Cell CORP showed a decrease of -6.8% in Total Assets from 2024 to 2025.
- This data is from International Stem Cell CORP's annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $8.11 million | Q3 2011: $7.32 million | Q1 2012: $10.59 million | Q2 2012: $8.91 million | Q3 2012: $7.12 million | Q1 2013: $6.82 million | Q2 2013: $6.10 million | Q3 2013: $6.93 million | Q1 2014: $6.65 million | Q2 2014: $6.62 million | Q3 2014: $6.36 million | Q1 2015: $6.69 million | Q2 2015: $6.89 million | Q3 2015: $7.23 million | Q1 2016: $8.39 million | Q2 2016: $7.86 million | Q3 2016: $7.54 million | Q1 2017: $7.86 million | Q2 2017: $7.61 million | Q3 2017: $7.95 million | Q1 2018: $7.47 million | Q2 2018: $8.42 million | Q3 2018: $8.73 million | Q1 2019: $8.66 million | Q2 2019: $8.54 million | Q3 2019: $8.26 million | Q1 2020: $6.88 million | Q2 2020: $6.78 million | Q3 2020: $5.85 million | Q1 2021: $6.02 million | Q2 2021: $5.61 million | Q3 2021: $4.94 million | Q1 2022: $5.50 million | Q2 2022: $5.42 million | Q3 2022: $5.04 million | Q1 2023: $5.34 million | Q2 2023: $5.79 million | Q3 2023: $5.64 million | Q1 2024: $5.37 million | Q2 2024: $5.59 million | Q3 2024: $5.18 million | Q1 2025: $5.62 million | Q2 2025: $5.55 million | Q3 2025: $5.28 million.
- Over the full 16 years of available data (2010 to 2025), International Stem Cell CORP's Total Assets has declined by 51.5%.
- Historical annual values: Fiscal year 2025: $4.82 million | Fiscal year 2024: $5.17 million | Fiscal year 2023: $5.39 million | Fiscal year 2022: $5.14 million | Fiscal year 2021: $4.95 million | Fiscal year 2020: $5.29 million | Fiscal year 2019: $6.62 million | Fiscal year 2018: $7.80 million | Fiscal year 2017: $6.86 million | Fiscal year 2016: $7.05 million | Fiscal year 2015: $7.14 million | Fiscal year 2014: $7.18 million | Fiscal year 2013: $7.74 million | Fiscal year 2012: $5.37 million | Fiscal year 2011: $5.74 million | Fiscal year 2010: $9.93 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: